Improved blood diagnostic
AssigneesFujirebio Europe N.V., Fujirebio Inc.
InventorsGuy MERSCH, Atsushi YAMAGUCHI, Katsumi AOYAGI, Ina VANDENBROUCKE
Life of this patent
Estimating the term…
Abstract
A method to quantify the abundance of Neurofilament light chain (NFL) in a blood sample, comprising the steps of adding a composition comprising a polyanionic molecule and of reacting it with at least one antibody coupled to a detection system, specifically binding to one epitope of the NFL, its use for a diagnostic application and the corresponding diagnostic kit.
Claims11
A method to quantify the abundance of Neurofilament light chain (NFL) in a blood sample, comprising the steps of supplementing to the said blood sample a composition comprising a polyanionic molecule and of reacting the said supplemented blood sample with at least one antibody, or a fragment thereof, coupled to a detection system, wherein the said polyanionic molecule has a molecular wight comprised between 5000 and 2000000 Da, and a charge density comprised between 1 and 20 negative charges per 1000 Da at a pH of 7, wherein the said polyanionic molecule is present in the supplemented blood sample in an amount between 0.01 wt % and 10 wt %, preferably between 0.1 wt % and 5 wt %, more preferably between 0.5 wt % and 1 wt % (weight polyanionic molecule:
- weight of the blood sample after supplementation), and wherein the said antibody, or the said antibody fragment, coupled to a detection system specifically binds to one epitope of the said NFL.
9-10. (canceled)
A diagnostic kit comprising:
- a first antibody, or a fragment thereof, specifically binding the Neurofilament light chain (NFL) and fixed on a support,
- a specific detection antibody for the NFL, or a fragment thereof, coupled to a detection system,
- a polyanionic molecule having a molecular weight comprised between 5000 and 2000000 Da, and a charge density comprised between 1 and 20 negative charges per 1000 Da at a pH of 7,
- wherein the said first antibody or the fragments thereof does not interfere with the binding of the said detection antibody, or of the fragment thereof to the NFL.
Dependencies are inferred from the claim text.